Genus (LON:GNS – Get Free Report)‘s stock had its “buy” rating reaffirmed by stock analysts at Berenberg Bank in a research report issued on Tuesday, Digital Look reports. They currently have a GBX 3,350 price objective on the stock. Berenberg Bank’s target price points to a potential upside of 42.07% from the company’s current price.
Genus Trading Down 0.1%
Shares of GNS stock opened at GBX 2,358 on Tuesday. The company has a current ratio of 2.22, a quick ratio of 1.08 and a debt-to-equity ratio of 14.02. Genus has a twelve month low of GBX 1,943 and a twelve month high of GBX 3,220. The company’s 50-day moving average price is GBX 2,231.31 and its 200-day moving average price is GBX 2,277.62. The stock has a market cap of £1.56 billion, a price-to-earnings ratio of 5.55, a PEG ratio of 2.87 and a beta of 0.90.
Genus (LON:GNS – Get Free Report) last announced its quarterly earnings results on Thursday, September 10th. The company reported GBX 110.30 earnings per share for the quarter. Genus had a net margin of 43.35% and a return on equity of 44.90%. As a group, equities analysts predict that Genus will post 70.96 earnings per share for the current year.
Insider Activity
In other news, insider Jorgen Kokke sold 50,236 shares of the company’s stock in a transaction on Monday, September 14th. The shares were sold at an average price of GBX 2,151, for a total value of £1,080,576.36. Insiders own 0.71% of the company’s stock.
Genus Company Profile
Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.
Read More
- Five stocks we like better than Genus
- ASML Can’t Keep Up With AI Demand—Why That’s a Good Thing
- Enovix’s 100,000-Battery Drone Order Sets Up a Test of Its Production Plans
- AMD’s Support Could Help Fermi Stock Overcome Its Biggest Hurdle
- Beyond the GPU: Credo Paves the Next AI Data Superhighway
Receive News & Ratings for Genus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genus and related companies with MarketBeat.com's FREE daily email newsletter.
